Loading...
US Funding Uncertainty Will Squeeze Life Sciences Yet Spark Resilience
AnalystLowTarget's Fair Value
US$53.00
10.7% overvalued intrinsic discount10 Sep
US$58.66
1Y
-20.0%7D
-6.8%1Y
-20.0%7D
-6.8%You can edit this narrative until Jun 22 10:22 PM. Then, changes will post as Updates.